. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease. Expert Opin Ther Targets. 2019 Jan;23(1):39-51. Epub 2018 Nov 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.